Eating fish and foods with omega-3 fatty acids linked to lower risk of age-related eye disease

June 9, 2008

Eating fish and other foods high in omega-3 fatty acids is associated with reduced risk of the eye disease age-related macular degeneration (AMD), according to a meta-analysis of nine previously published studies in the June issue of Archives of Ophthalmology. However, the accumulated evidence includes few clinical trials and is insufficient to support the routine consumption of such foods for AMD prevention, the authors note.

"Age-related macular degeneration (AMD) is the leading cause of severe vision loss among elderly people," they write as background information in the article. New treatments for AMD are potentially risky and treat only certain forms of the disease. "Thus, primary prevention of AMD by modifying risk factors (e.g., cigarette smoking) remains an important public health strategy."

Elaine W-T. Chong, M.B.B.S., of the University of Melbourne, Australia, and colleagues conducted a systematic review of studies published before May 2007 evaluating the fish consumption and overall omega-3 fatty acid intake for the prevention of AMD. A total of nine studies were identified with 88,974 participants, including 3,203 individuals with AMD.

When results from all nine studies were combined, a high dietary intake of omega-3 fatty acids was associated with a 38 percent reduction in the risk of late (more advanced) AMD, while eating fish twice a week was associated with a reduced risk of both early and late AMD.

"Long-chain omega-3 fatty acids, docosahexaenoic acid in particular, form an integral part of the neural retina," the layer of nerve cells in the retina, the authors write. Outer cells of the retina are continually shed and regenerated, and deficiencies of omega-3 fatty acids may therefore initiate AMD. "A diet rich in omega-3 fatty acids and fish, as a proxy for long-chain omega-3 fatty acid intake, has therefore been hypothesized as a means to prevent AMD."

Source: JAMA and Archives Journals


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 4.4 /5 (8 votes)


June 9, 2008 all stories

Comments: 0

4.4 /5 (8 votes)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

Other News

Climate variability and dengue incidence

Medicine & Health / Diseases

created 36 minutes ago | popularity not rated yet | comments 0

Research published this week in PLoS Medicine demonstrates associations between local rainfall and temperature and cases of dengue fever, which affects an estimated fifty million people per year worldwide. But the study ...


Early cooling in cardiac arrest may improve survival

Medicine & Health / Other

created 19 minutes ago | popularity not rated yet | comments 0

Rapidly cooling a person in cardiac arrest may improve their chance of survival without brain damage, according to research presented at the American Heart Association's Scientific Sessions 2009.


Pilot study relates phthalate exposure to less-masculine play by boys

Medicine & Health / Research

created 2 hours ago | popularity 4 / 5 (2) | comments 2

A study of 145 preschool children reports, for the first time, that when the concentrations of two common phthalates in mothers' prenatal urine are elevated their sons are less likely to play with male-typical toys and games, ...


New study links vitamin D deficiency to cardiovascular disease and death

Medicine & Health / Health

created 2 hours ago | popularity not rated yet | comments 0

While mothers have known that feeding their kids milk builds strong bones, a new study by researchers at the Heart Institute at Intermountain Medical Center in Salt Lake City suggests that Vitamin D contributes to a strong ...


Study raises new questions about Merck pill Zetia

Medicine & Health / Medications

created 2 hours ago | popularity not rated yet | comments 0

(AP) -- A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.